Cargando…
Novel Perspectives on the Design and Development of a Long-Acting Subcutaneous Raltegravir Injection for Treatment of HIV—In Vitro and In Vivo Evaluation
Antiretrovirals (ARVs) are a highly effective therapy for treatment and prevention of HIV infection, when administered as prescribed. However, adherence to lifelong ARV regimens poses a considerable challenge and places HIV patients at risk. Long-acting ARV injections may improve patient adherence a...
Autores principales: | Abd-Ellah, Heba S., Mudududdla, Ramesh, Carter, Glen P., Baell, Jonathan B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224444/ https://www.ncbi.nlm.nih.gov/pubmed/37242770 http://dx.doi.org/10.3390/pharmaceutics15051530 |
Ejemplares similares
-
Design, Development, and Optimisation of Smart Linker Chemistry for Targeted Colonic Delivery—In Vitro Evaluation
por: Abd-Ellah, Heba S., et al.
Publicado: (2023) -
Raltegravir Attenuates Experimental Pulmonary Fibrosis In Vitro and In Vivo
por: Zhang, Xue, et al.
Publicado: (2019) -
HIV resistance to raltegravir
por: Clavel, François
Publicado: (2009) -
The protective role of raltegravir in experimental acute lung injury in vitro and in vivo
por: Xu, Zehui, et al.
Publicado: (2022) -
Raltegravir in the management of HIV-infected patients
por: Stellbrink, Hans-Jürgen
Publicado: (2009)